Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000898822-05-000132
Filing Date
2005-03-08
Accepted
2005-03-08 15:52:57
Documents
3
Period of Report
2005-02-20

Document Format Files

Seq Description Document Type Size
1 form3a_ex.html 3/A  
1 form3a_ex.xml 3/A 4049
2 EXHIBIT 99.1 form3991.txt EX-99 2243
3 EXHIBIT 99.2 form3992.txt EX-99 2944
  Complete submission text file 0000898822-05-000132.txt   11744
Mailing Address 520 WHITE PLAINS RD TARRYTOWN NY 10591
Business Address 520 WHITE PLAINS RD TARRYTOWN NY 10591
NOVARTIS CORP (Reporting) CIK: 0001031007 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-31333 | Film No.: 05666849

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-31333 | Film No.: 05666850
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 -15 NORTH CONDUIT AVE LAURELTON NY 11413
Business Address 787 SEVENTH AVE NEW YORK NY 10019 2127288116
EON LABS INC (Issuer) CIK: 0001168061 (see all company filings)

EIN.: 133653818 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations